Metraipolis › archive › dc_f50eb8aac7ac
Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy — Europe PMC PMID:41633975
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41633975
- DOI
- 10.1038/s41419-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T03:51:42.233Z
- SHA-256 of the archived text
d94674a2d2cec8347b407a499d4c05dd734b8d92701edd32697ce78eca89f1fc- Stable URL of this page
https://metraipolis.com/documento/dc_f50eb8aac7ac
How to cite
Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy — Europe PMC PMID:41633975 — Europe PMC (en), https://europepmc.org/article/MED/41633975 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f50eb8aac7ac (Metraipolis archive dc_f50eb8aac7ac, sha256 d94674a2d2cec8347b407a499d4c05dd734b8d92701edd32697ce78eca89f1fc)
BibTeX
@misc{dcf50eb8aac7ac,
title = {Immune checkpoint inhibitor-related pneumonitis: current advances and the putative role of mesenchymal stem cell therapy — Europe PMC PMID:41633975},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41633975},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f50eb8aac7ac; sha256 d94674a2d2cec8347b407a499d4c05dd734b8d92701edd32697ce78eca89f1fc},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41633975. Agents can read the archived copy with the MCP tool read_document.